Prot #M10-877: A Multicenter Study of The Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis

Project: Research project

Project Details

StatusFinished
Effective start/end date5/10/135/10/16

Funding

  • AbbVie Inc. (Prot #M10-877)